Treatment is mostly supportive. Ribavirin has shown some efficacy in vitro and has been used by mouth during outbreaks, but there is uncertain evidence to support its use, and this medication can cause serious side effects including hemolytic anemia and liver damage. the use of Immunoglobulin preparations has remained unproven and antibody engineering, which raised hopes for monoclonal antibody therapy, has remained in its infancy.
Crimean–Congo hemorrhagic fever
Ebola
Omsk hemorrhagic fever
Dengue fever
Bolivian hemorrhagic fever
Q fever
Blackwater fever
Argentine hemorrhagic fever